Semax specifications and research profile
Specifications summary
| Designation | Synthetic ACTH(4-7)-Pro-Gly-Pro heptapeptide |
|---|---|
| Also known as | Semax |
| Sequence / composition | Met-Glu-His-Phe-Pro-Gly-Pro |
| Strength | 10mg |
| Presentation | Powder vial |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
Semax is a synthetic heptapeptide comprising the ACTH(4-7) sequence followed by Pro-Gly-Pro. It is studied as a short regulatory-peptide reference without the full adrenocorticotropic hormone sequence.
Preclinical studies have examined neurotrophin and receptor-gene transcription in rat brain models, while biochemical work has characterised Semax-copper complexes and cell-line responses. These findings are model-specific and do not establish a defined outcome in humans or animals.
Applications in research
- ACTH-fragment and Pro-Gly-Pro structure-activity comparisons
- Neurotrophin and receptor-gene transcription studies
- Peptide-metal binding and cell-response assays
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Semax research record
Clear product, batch, storage, dispatch and document information for this powder vial.
Research context
A synthetic peptide used in laboratory research involving neuropeptide signalling, peptide stability, and analytical comparison models.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.